Latest / Your Way Home with Hongbin Jeong
Under the Radar: The role of Generative AI on drug discovery – Insilico Medicine’s CEO on positioning against large pharma players; Global market for AI enabled drug discovery to grow at a CAGR of 26.3%; Collaboration with Sanofi worth up to US$1.2b
From content writing, to providing human-like responses in chatbots, and to even coding. Generative AI has made its potential known to the world with the introduction of ChatGPT. But besides, did you know that generative AI can be used in the process of drug discovery as well? Today we speak with Insilico Medicine, a clinical stage AI driven drug discovery company that is delivering breakthrough solutions to discover and develop medicines in areas such as cancer, immunity and ageing. The company was selected by NVIDIA as one of the top 5 AI companies for its potential for social impact back…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.